Study of Ferumoxytol Enhanced MRI for Detecting Lymph Node Metastases in Prostate, Bladder, and Kidney Cancers

NCT02141490 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

43

Enrollment

NIH

Sponsor class

Conditions

Prostate Cancer
Bladder Cancer
Kidney Cancer

Interventions

DRUG: Ferumoxytol
DIAGNOSTIC_TEST: Magnetic Resonance Imaging (MRI)

Sponsor

National Cancer Institute (NCI)